2.8.3. Analysis of the primary endpoint.
pain
The primary endpoint of the study is the change in the VAS scores for dermal pain induced by thermal load before and after treatment with icatibant or placebo. The FAS will be used as the analysis population to compare the changes in VAS scores between the 2 treatments at a significance of 